VIVO - Meridian Bioscience EPS misses by $0.09 misses on revenue
Meridian Bioscience (NASDAQ:VIVO): FQ3 Non-GAAP EPS of $0.22 misses by $0.09; GAAP EPS of $0.27 misses by $0.05. Revenue of $63.51M (-25.1% Y/Y) misses by $9.61M. Press Release
For further details see:
Meridian Bioscience EPS misses by $0.09, misses on revenue